Breaking News

SGS Adds Stability Testing Services in UK

March 11, 2013

Expands analytical testing for biologics

SGS Life Science Services is developing integrated formulation and stability testing services in the UK, expanding its current capability for characterization-based analytical testing for biologics. The new services will be offered from a dedicated suite in its M-Scan facility in Wokingham, UK and is scheduled to be fully operational by 4Q13.
 
The 1,100 sq.-ft. suite will include a temperature and access controlled room for the stability units and a large separate instrumentation and wet lab. These new services extend SGS’s formulation and stability services currently provided in Lincolnshire, IL, and stability testing services from its Center of Excellence in Berlin, Germany.
 
“Customers require preparation and testing of their samples at one site. Sample shipment involved in multisite testing is not ideal because of the potential effects that shipping may have on sample integrity,” said Andrew Reason, group manager, SGS M-Scan Europe. “These studies are also an iterative process whereby data is fed back to the formulation scientists prior to generation of further samples for testing.”
 
Anne Hays, executive vice president, SGS Life Science Services, said, “There is an increasing trend for biologics manufacturers to outsource testing of their products and SGS strives to provide new services in response to the market’s needs in a timely manner.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important